Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
Centre for Applied Dementia Studies at the University of Bradford becomes the first institution in Europe to receive the ADI Accreditation, marking a historic milestone for University of Bradford and ADI
In November 2023, the ECLAC policy leaders convened in Santiago, Chile, to commemorate the 10th Anniversary of the Montevideo Consensus. Regional Director for the Americas, Diego Aguilar reflects on this meeting, and the importance of funded National Dementia Plans to ensure social protection for the ageing population of the Latin American and Caribbean regions.
October signaled another busy month for ADI, with our and board members travelling internationally to capitalize on the growing momentum; from Buenos Aires, Brunei Darussalam, Helsinki, Lausanne, Tbilisi, to The Hague.
ADI and ADI Member, Febraz, participated in a public hearing held by the Human Rights Commission at the Brazilian Federal Senate, to debate public policies for the care of people living with dementia
The resulting declaration includes an essential call for Member States of the WHO to extend the Global Action Plan on dementia to 2035
As World Alzheimer’s Month comes to a close, we reflect on some of the highlights from this year’s campaign
Each year, ADI hosts its Alzheimer University for emerging associations, aiming to equip new associations with the skills and knowledge needed to run a successful Alzheimer or dementia association.
The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.